China: largest pharmaceutical companies by assets 2022

According to the annual ranking of Forbes Global 2000 which measures the world's largest public companies, Sinopharm Group ranked first among Chinese pharmaceutical companies in terms of total assets - approximately 52.6 billion U.S. dollars in 2022's ranking. Hubei Biocause Pharmaceutical took the second place with 39.13 billion U.S. dollars of assets value.

Largest Chinese pharmaceutical companies as compiled by the Forbes Global 2000 ranking as of May 2022, by assets* (in billion U.S. dollars)

Characteristic	Assets value in billion U.S. dollars
Sinopharm Group	52.63
Hubei Biocause Pharmaceutical	39.13
Shanghai Pharmaceuticals	25.64
Shanghai Fosun Pharmaceutical	14.63
Jointown Pharmaceutical Group	14.43
WuXi Biologics	6.91
Jiangsu Hengrui Medicine	6.03
Chongqing Zhifei Biological Products	4.71
Zhangzhou Pientzehuang Pharmaceutical	1.96

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

May 2022

More information

Region

China

Survey time period

2022

Special properties

figures based on the latest 12-month's financial data available

Supplementary notes

*Assets value is just one of four metrics used by the Forbes for company ranking. The ranking and placement on the Forbes Global 2000 list is determined by company's sales, profit, assets, and market value combined.

Citation formats